CHU de NICE
Nice, CHU de Nice, 06200, France
Location status: Recruiting
NCT Number: NCT07388381
The use of long-term peripheral venous catheters inserted in the upper limb (PICC lines and Midlines) has increased markedly over recent years.
Catheter-related bacteremias and venous thromboses are the main complications associated with these catheters. These events may occur independently or simultaneously. In addition, venous thromboses may involve the superficial venous system (SVT) or the deep venous system (DVT).
Current guidelines define septic thrombophlebitis as the association of a bacteremia and a DVT along the venous course of the catheter. This represents a severe complication of catheter-related bacteremia, leading to a modification in the duration of antibiotic therapy. However, SVTs associated with catheter-related bacteremias along the catheter pathway are not included in the definition of septic thrombophlebitis and are not addressed by specific recommendations.
The objective of this study is therefore to assess the impact of upper-limb SVT on the frequency of unfavorable outcomes in catheter-related bacteremias related to PICC and Midline catheters, in order to determine whether superficial venous thrombosis occurring in the context of a catheter-related bacteremia should be considered a distinct entity not falling under the diagnosis of septic thrombophlebitis (and therefore not requiring a modification of antibiotic treatment duration, in accordance with current guidelines), or whether, conversely, it should be considered equivalent to septic thrombophlebitis, as is the case for deep venous thrombosis.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Nice, CHU de Nice, 06200, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Clinical follow-up and outcomes of patients with catheter-related bacteremia
Time frame: At day 28 after completion of treatment for catheter-related bacteremia
An unfavorable outcome is defined as a composite endpoint including at least one of the following:
Time frame: At day 28 after completion of treatment for catheter-related bacteremia
Comparison of patient parameters and management with the course of catheter-related bacteremia
Time frame: At day 14 after completion of treatment for catheter-related bacteremia
Comparison of echo-doppler imaging between inclusion and 14 days after antibiotics treatment
Contact information is provided by the study sponsor or research team.
Dylan MAZZOLENI
CONTACT
Elisa DEMONCHY
CONTACT
Centre Hospitalier Universitaire de Nice
Other
Acronym: THROMBI-CATH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06714864
Catheter-Related Infections, Infections
Birmingham, Alabama, United States
View Trial DetailsNCT07233837
Antimicrobial, Catheter Related Blood Stream Infections
Barbalha, Ceará, Brazil
View Trial DetailsNCT06770374
Cardiovascular Diseases, Catheter-Related Infections
Lleida, Catalonia, Spain
View Trial DetailsNCT06478160
Acceptability of Health Care, Anemia
Madrid, Spain
View Trial Details